Zacks.com on MSN1d
VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares UpVertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid, highly selective NaV1.8 pain signal inhibitor, suzetrigine, for the treatment of adults with moderate ...
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback